FDA Civil Monetary Penalties Increase Across the Board to Keep Pace with Inflation Post author:Sam Post published:February 2, 2017 Post category:Drug Industry Daily The FDA’s civil monetary penalties are increasing to adjust for inflation at under 2 percent. Source: Drug Industry Daily You Might Also Like FTC Deluged With More Than 24,000 Comments About PBMs’ Effect on Patients and Payers June 1, 2022 ICER Issues Cost-Benefit Analysis on Three Sickle Cell Disease Treatments January 24, 2020 Supreme Court Considers 340B Drug Discount Program, While Yet Another Drugmaker Drops Out December 2, 2021
Supreme Court Considers 340B Drug Discount Program, While Yet Another Drugmaker Drops Out December 2, 2021